These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20037305)

  • 21. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.
    Alberts SR; Horvath WL; Sternfeld WC; Goldberg RM; Mahoney MR; Dakhil SR; Levitt R; Rowland K; Nair S; Sargent DJ; Donohue JH
    J Clin Oncol; 2005 Dec; 23(36):9243-9. PubMed ID: 16230673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603.
    Kanemitsu Y; Kato T; Shimizu Y; Inaba Y; Shimada Y; Nakamura K; Sato A; Moriya Y;
    Jpn J Clin Oncol; 2009 Jun; 39(6):406-9. PubMed ID: 19389795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Safety and efficacy of FOLFOX and FOLFIRI in elderly patients with colorectal cancer].
    Mishima H; Ikenaga M; Yasui M
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():554-8. PubMed ID: 22214022
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hepatic resection after neoadjuvant therapy for initially unresectable colorectal liver metastases].
    Kaibori M; Iwamoto S; Ishizaki M; Matsui K; Saito T; Yoshioka K; Kwon AH
    Gan To Kagaku Ryoho; 2009 Dec; 36(13):2579-82. PubMed ID: 20009458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recovery of liver function after the cessation of preoperative chemotherapy for colorectal liver metastasis.
    Takamoto T; Hashimoto T; Sano K; Maruyama Y; Inoue K; Ogata S; Takemura T; Kokudo N; Makuuchi M
    Ann Surg Oncol; 2010 Oct; 17(10):2747-55. PubMed ID: 20425145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of sequential chemotherapy in the treatment of metastatic colorectal cancer].
    Tassinari D; Tamburini E; Carloni F; Nicoletti S; Ravaioli A
    Recenti Prog Med; 2009 Feb; 100(2):73-9. PubMed ID: 19350798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of taste disorders following FOLFOX-FOLFIRI therapy and its effects on the QOL of patients with colorectal cancer].
    Takimoto N; Sugawara S; Iida A; Sakakibara T; Mori K; Sugiura M; Yamamura K; Adachi M
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):431-5. PubMed ID: 19295267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
    Ishizuka M; Nagata H; Takagi K; Kubota K
    Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The timing of surgery for resectable metachronous liver metastases from colorectal cancer: Better sooner than later? A retrospective analysis.
    Scartozzi M; Siquini W; Galizia E; Stortoni P; Marmorale C; Berardi R; Fianchini A; Cascinu S
    Dig Liver Dis; 2011 Mar; 43(3):194-8. PubMed ID: 20728416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful right hepatectomy after four treatments of yttrium-90 microspheres (SIR-Spheres) and concomitant FOLFOX as bridging therapy to resection of colorectal liver metastases.
    Chua TC; Bester L; Akther J; Morris DL
    Anticancer Res; 2010 Jul; 30(7):3005-7. PubMed ID: 20683046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Significance of Surgical Margin Size After Neoadjuvant FOLFOX and/or FOLFIRI for Colorectal Liver Metastases.
    Miller CL; Taylor MS; Qadan M; Deshpande V; Worthington S; Smalley R; Collura C; Ryan DP; Allen JN; Blaszkowsky LS; Clark JW; Murphy JE; Parikh AR; Berger D; Tanabe KK; Lillemoe KD; Ferrone CR
    J Gastrointest Surg; 2017 Nov; 21(11):1831-1840. PubMed ID: 28884391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of liver failure associated with liver damage due to mFOLFOX 6 after resection for multiple liver metastases from colorectal cancer].
    Ishizaki T; Abe T; Koyanagi Y; Katsumata K; Wada T; Tsuchida A; Aoki T
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):945-8. PubMed ID: 17565263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancer.
    Limat S; Bracco-Nolin CH; Legat-Fagnoni C; Chaigneau L; Stein U; Huchet B; Pivot X; Woronoff-Lemsi MC
    Eur J Health Econ; 2006 Jun; 7(2):107-13. PubMed ID: 16474968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
    Shitara K; Munakata M; Muto O; Kasai M; Okada R; Mitobe S; Sakata Y
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1079-84. PubMed ID: 17637544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
    Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
    Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical study of irinotecan plus infusional fluorouracil/l-leucovorin (FOLFIRI) in patients with fluoropyrimidine-resistant metastatic colorectal cancer].
    Moriwaki T; Hyodo I; Nishina T; Kajiwara T; Kataoka J; Hori S; Nasu J; Imamine S; Iguchi H
    Gan To Kagaku Ryoho; 2007 Dec; 34(13):2249-53. PubMed ID: 18079624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility and short-term outcome of adjuvant FOLFOX after resection of colorectal liver metastases.
    Sakamoto Y; Beppu T; Miyamoto Y; Okabe H; Ida S; Imai K; Chikamoto A; Watanabe M; Takamori H; Baba H
    J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):307-12. PubMed ID: 22610308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neoadjuvant chemotherapy and pancreatoduodenectomy for locally advanced colon cancer].
    Miki Y; Ikenaga M; Miyamoto A; Tsujie M; Yasui M; Miyazaki M; Hirao M; Fujitani K; Mishima H; Nakamori S; Tsujinaka T
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2220-2. PubMed ID: 20037376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of metastatic colorectal cancer: analysis of a consecutive series of 229 patients. The impact of a multidisciplinary approach.
    Sperti E; Faggiuolo R; Gerbino A; Magnino A; Muratore A; Ortega C; Ferraris R; Leone F; Capussotti L; Aglietta M
    Dis Colon Rectum; 2006 Oct; 49(10):1596-601. PubMed ID: 16988853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment patterns and metastasectomy among mCRC patients receiving chemotherapy and biologics.
    Song X; Zhao Z; Barber B; Gregory C; Wang PF; Long SR
    Curr Med Res Opin; 2011 Jan; 27(1):123-30. PubMed ID: 21128878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.